CTI Clinical Trials

CTI Clinical Trials is a privately held, US-based contract research organization with over two decades of experience, headquartered in Cincinnati, Ohio. It operates as a service provider, offering end-to-end clinical trial management and strategic consulting, with a pronounced focus on complex therapeutic areas like oncology and rare diseases. The company's business model is built on delivering specialized operational and regulatory support to biopharma sponsors, positioning it as a niche player in the competitive CRO landscape. Its long-standing presence suggests stability and deep client relationships in its core sectors.

Integrated clinical trial service platform encompassing trial design, project management, monitoring, data management, biostatistics, and regulatory affairs, with specialized therapeutic expertise in oncology and rare diseases.

CTI operates in a highly fragmented and competitive CRO market. It competes with large, full-service public CROs (e.g., IQVIA, ICON, Labcorp) and larger private peers (e.g., Parexel) on global scale and breadth of services. Its competitive differentiation is its focused therapeutic expertise in oncology and rare diseases, positioning it against other specialty CROs and the specialized units of larger players.